A Study To Assess The Safety Of PF-06342674 In Adults With Type 1 Diabetes
Public ClinicalTrials.gov record NCT02038764. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 1 Study To Evaluate The Safety, Tolerability, Immunogenicity, Pharmacokinetics And Pharmacodynamics Of Multiple Ascending Doses Of Pf-06342674 (rn168) In Adults With Type 1 Diabetes
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to evaluate the safety, tolerability, pharmacokinetics and immunogenicity of multiple doses of PF-06342674. Several dose levels will be evaluated.
Study identification
- NCT ID
- NCT02038764
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 1
- Enrollment
- 37 participants
Conditions and interventions
Conditions
Interventions
- Placebo Drug
- PF-06342674 Dose A Biological
- PF-06342674 Dose B Biological
- PF-06342674 Dose C Biological
- PF-06342674 Dose D Biological
Drug · Biological
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jun 4, 2014 (Actual)
- Primary completion
- Sep 13, 2016 (Actual)
- Completion
- Sep 13, 2016 (Actual)
- Last update posted
- Aug 3, 2018
2014 – 2016
United States locations
- U.S. sites
- 21
- U.S. states
- 9
- U.S. cities
- 10
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| VA San Diego Healthcare System (Drug Shipment) | San Diego | California | 92161 | — |
| Veterans Administration San Diego Healthcare System | San Diego | California | 92161 | — |
| University of California, San Francisco | San Francisco | California | 94143 | — |
| Barbara Davis Center | Aurora | Colorado | 80045 | — |
| Yale School of Medicine | New Haven | Connecticut | 06510 | — |
| Yale New Haven Hospital - Investigational Drug Services | New Haven | Connecticut | 06511 | — |
| Yale University School of Medicine | New Haven | Connecticut | 06519 | — |
| Atlanta Diabetes Associates | Atlanta | Georgia | 30318 | — |
| Duchossois Center for Advanced Medicine | Chicago | Illinois | 60637 | — |
| The University of Chicago Medical Center | Chicago | Illinois | 60637 | — |
| University of Chicago Clinical Resource Center | Chicago | Illinois | 60637 | — |
| University of Chicago Medical Center | Chicago | Illinois | 60637 | — |
| Umass Memorial Medical Center | Worcester | Massachusetts | 01655 | — |
| University of Massachusetts Medical School | Worcester | Massachusetts | 01655 | — |
| University Of Minnesota Fairview Pharmacy Services | Minneapolis | Minnesota | 55454 | — |
| University Of Minnesota Medical School | Minneapolis | Minnesota | 55455 | — |
| Barnes- Jewish HOSP Att: Kathryn Vehe | St Louis | Missouri | 63110 | — |
| Washington University - Center for Advanced Medicine | St Louis | Missouri | 63110 | — |
| Washington University | St Louis | Missouri | 63110 | — |
| Duke Clinical Research Unit | Durham | North Carolina | 27710 | — |
| Duke University Health Systems (DUHS) Investigational Drug Services | Durham | North Carolina | 27710 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02038764, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Aug 3, 2018 · Synced Oct 28, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT02038764 live on ClinicalTrials.gov.